Solid Biosciences Files 8-K: Director Changes & Shareholder Votes
Ticker: SLDB · Form: 8-K · Filed: Jun 13, 2025 · CIK: 1707502
| Field | Detail |
|---|---|
| Company | Solid Biosciences Inc. (SLDB) |
| Form Type | 8-K |
| Filed Date | Jun 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing, disclosure
TL;DR
Solid Biosciences filed an 8-K detailing director changes and shareholder votes.
AI Summary
Solid Biosciences Inc. announced on June 12, 2025, several key events including the departure of a director, the election of a new director, and updates to executive compensatory arrangements. The company also submitted matters to a vote of security holders and filed financial statements and exhibits. These events are detailed in their Form 8-K filing.
Why It Matters
This filing indicates significant corporate governance changes and potential shareholder engagement on important company matters, which could impact investor confidence and strategic direction.
Risk Assessment
Risk Level: low — The filing reports routine corporate governance events and disclosures, not immediate financial distress or major operational shifts.
Key Players & Entities
- Solid Biosciences Inc. (company) — Registrant
- June 12, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-38360 (identifier) — Commission File Number
- 90-0943402 (identifier) — IRS Employer Identification No.
- 500 Rutherford Avenue, Charlestown, Massachusetts 02129 (address) — Principal Executive Office Address
FAQ
Who departed as a director of Solid Biosciences Inc.?
The filing indicates the departure of a director, but the specific name is not provided in the excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 12, 2025.
What are the main items reported in this Form 8-K?
The filing covers the departure of directors, election of directors, compensatory arrangements of officers, submission of matters to a vote of security holders, and financial statements/exhibits.
In which state is Solid Biosciences Inc. incorporated?
Solid Biosciences Inc. is incorporated in Delaware.
What is the business address of Solid Biosciences Inc.?
The business address is 500 Rutherford Avenue, 3rd Floor, Charlestown, Massachusetts 02129.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 13, 2025 regarding Solid Biosciences Inc. (SLDB).